133 results
Page 2 of 7
425
khwafikju2c ebgeh
22 May 23
Business combination disclosure
7:01am
8-K
bumwm9fj
22 May 23
Other Events
6:59am
8-K
EX-99.1
6eha mqbt9ga0m1qa
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
m9eg818pg
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
10173a0
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
4vt5aiaqxou10a
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-99.1
5grkp
25 Oct 22
Adaptimmune Enhances its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK
8:10am
8-K
qgl zdxz2
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
vyi8rwrx
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am